Severe Demyelinating Neuropathy in an Advanced Melanoma Patient Treated with Nivolumab plus Ipilimumab Combined Therapy

Immune checkpoint inhibitors (ICIs) significantly prolong survival in patients with metastatic melanoma but can lead to serious immune-related adverse events. In this report, we described a case of atypical neuropathy caused by nivolumab plus ipilimumab combination therapy before primary tumor resec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Case Rep Oncol
Autores principales: Kambayashi, Yumi, Fujimura, Taku, Kuroda, Hiroshi, Otsuka, Atsushi, Irie, Hiroyuki, Aiba, Setsuya
Formato: Artigo
Lenguaje:Inglês
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7250384/
https://ncbi.nlm.nih.gov/pubmed/32508619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000506976
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares